Sign in

CIK 0001746473

  • Non-accelerated filer
  • Smaller reporting company

PLIANT THERAPEUTICS, INC.

Sign in to watch
Ticker
PLRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474272481
Phone
+1 650-481-6770
Business address
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market sale President and CEO sold 3,500 shares at an average $26.38 ($92,325)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Option exercise Chief Business Officer acquired 3,500 shares (option exercise)
  8. 4 Option exercise Chief Financial Officer acquired 4,500 shares (option exercise)
  9. 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $26.54 ($331,752)
  10. 4 Open-market sale President and CEO sold 3,500 shares at an average $27.37 ($95,790)
  11. 4 Open-market sale Chief Financial Officer sold 18,734 shares at an average $30.00 ($562,035)
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Conversion Chief Business Officer acquired 8,900 shares (conversion)
  15. 4 Conversion Director acquired 139,860 shares (conversion)
  16. 4 Option exercise Chief Financial Officer acquired 19,300 shares (option exercise)
  17. 4 Conversion Chief Human Resource Officer acquired 3,821 shares (conversion)
  18. 4 Conversion 10% owner acquired 7,692,307 shares (conversion)
  19. 4 Conversion Director acquired 0 shares (conversion)
  20. 4 Option exercise President and CEO acquired 48,840 shares (option exercise)

Page 10 of 11 · 215 filings